Pharmabiz

Xcision Medical's GammaPod stereotactic radiotherapy system receives CE mark for breast cancer treatment

Systems LLC, a medical technology company, announced that the GammaPod stereotactic radiotherapy system has received CE marking, paving the way for new sales in Europe and offering patients the latest ...
Business Insider

Xcision Receives FDA 510(k) Clearance for the GammaPod Stereotactic Radiotherapy System for Breast Cancer

COLUMBIA, Md., Jan. 9, 2018 /PRNewswire/ -- Xcision Medical Systems, LLC has announced that the GammaPod Stereotactic Radiotherapy System, the world's first noninvasive external beam system optimized ...
The Business Journals

Groundbreaking therapy for early-stage breast cancer results in shorter treatment schedule, fewer side effects, better cosmetic outcomes

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Allegheny Health Network (AHN) is one of the first medical ...
Pharmabiz

US FDA clears Xcision's GammaPod Stereotactic Radiotherapy System for breast cancer

Xcision Medical Systems, LLC has announced that the GammaPod Stereotactic Radiotherapy System, the world's first noninvasive external beam system optimized for partial breast treatments, has received ...